Scientech Research LLC Royalty Pharma PLC Transaction History
Scientech Research LLC
- $189 Billion
- Q1 2024
A detailed history of Scientech Research LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Scientech Research LLC holds 8,973 shares of RPRX stock, worth $232,221. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,973Holding current value
$232,221% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.14 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$976 Million0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$549 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$431 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$297 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...